Recent estimates of the structure of the factor VIIa (FVIIa)/tissue factor (TF) and factor Xa (FXa) ternary complex.

[1]  R. Galeazzi.  Molecular Dynamics as a Tool in Rational Drug Design: Current Status and Some Major Applications , 2009 .

[2]  S. Everse,et al.  Proposed structural models of human factor Va and prothrombinase , 2007, Journal of thrombosis and haemostasis : JTH.

[3]  Narayanaswamy Srinivasan,et al.  Nucleic Acids Research Advance Access published June 21, 2007 PIC: Protein Interactions Calculator , 2007 .

[4]  A. Rezaie,et al.  Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X. , 2007, Biochemistry.

[5]  O. Olsen,et al.  A loop of coagulation factor VIIa influencing macromolecular substrate specificity , 2007, FEBS letters.

[6]  A. Schmidt,et al.  High Resolution Structures of p-Aminobenzamidine- and Benzamidine-VIIa/Soluble Tissue Factor , 2006, Journal of Biological Chemistry.

[7]  Dougald M Monroe,et al.  A cell-based model of thrombin generation. , 2006, Seminars in thrombosis and hemostasis.

[8]  E. Persson,et al.  Activity, folding, misfolding, and aggregation in vitro of the naturally occurring human tissue factor mutant R200W. , 2005, Biochemistry.

[9]  T. Darden,et al.  An all‐atom solution‐equilibrated model for human extrinsic blood coagulation complex (sTF–VIIa–Xa): a protein–protein docking and molecular dynamics refinement study , 2003, Journal of thrombosis and haemostasis : JTH.

[10]  A. Olson,et al.  The tissue factor/factor VIIa/factor Xa complex: A model built by docking and site‐directed mutagenesis , 2003, Proteins.

[11]  P. Freskgård,et al.  Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor. , 2003, European journal of biochemistry.

[12]  Ram Samudrala,et al.  Rappertk: a versatile engine for discrete restraint-based conformational sampling of macromolecules , 2007, BMC Structural Biology.

[13]  O. Olsen,et al.  Assignment of molecular properties of a superactive coagulation factor VIIa variant to individual amino acid changes. , 2002, European journal of biochemistry.

[14]  F. Bernardi,et al.  A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. , 2002, The Biochemical journal.

[15]  D. Monroe,et al.  A Cell-based Model of Hemostasis , 2001, Thrombosis and Haemostasis.

[16]  R. Kelley,et al.  The tissue factor region that interacts with factor Xa in the activation of factor VII. , 2001, Biochemistry.

[17]  R. Kelley,et al.  The tissue factor region that interacts with substrates factor IX and Factor X. , 2000, Biochemistry.

[18]  T Darden,et al.  New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. , 1999, Structure.

[19]  R. St Charles,et al.  Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. , 1999, Journal of molecular biology.

[20]  A. Olson,et al.  Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain. , 1999, Biochemistry.

[21]  R. Abseher,et al.  Essential spaces defined by NMR structure ensembles and molecular dynamics simulation show significant overlap , 1998, Proteins.

[22]  L. Li,et al.  Refinement of the NMR solution structure of the gamma-carboxyglutamic acid domain of coagulation factor IX using molecular dynamics simulation with initial Ca2+ positions determined by a genetic algorithm. , 1997, Biochemistry.

[23]  P. Neuenschwander,et al.  Substrate Recognition by Tissue Factor-Factor VIIa , 1996, The Journal of Biological Chemistry.

[24]  David W. Banner,et al.  The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.

[25]  P. Neuenschwander,et al.  Substrate Recognition by Tissue Factor-Factor VIIa EVIDENCE FOR INTERACTION OF RESIDUES Lys AND Lys OF TISSUE FACTOR WITH THE 4-CARBOXYGLUTAMATE-RICH DOMAIN OF FACTOR X* , 1996 .

[26]  W. Ruf,et al.  Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor. , 1995, Biochemistry.

[27]  W. Ruf.  Factor VIIa residue Arg290 is required for efficient activation of the macromolecular substrate factor X. , 1994, Biochemistry.

[28]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[29]  A. Rehemtulla,et al.  Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VII. , 1992, The Journal of biological chemistry.

[30]  P. Hass,et al.  Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. , 1991, The Journal of biological chemistry.

[31]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .